Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...

Side-view of the human eye, viewed approximately 90° temporal. Image by Paul Savage. CC BY 2.0 Side-view of the human eye, viewed approximately 90° temporal. Image by Paul Savage. CC BY 2.0 Drug ...

Finding a new medicine is never easy. But developing treatments for patients with rare diseases — conditions that afflict fewer than 200,000 people in the United States — is particularly challenging.

Wesley Greenblatt, Harvard University, Boston Children’s Hospital, and Massachusetts Institute of Technology, Boston, Massachusetts. Charu Gupta, University of California Los Angeles, Los Angeles, ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

We're all familiar with the dilemma: It takes an average of 9.5 to 15 years to develop a new drug at a cost as high as $2.6 billion, with only a fraction of the drugs making it to market. With AI and ...

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study. A combination treatment incorporating three existing drugs -- tamsulosin, metoprolol and ...

New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to Treat Patients ...

As the summer of 2021 started to unfold, many Americans thought the pandemic was beginning to fizzle out. But that illusion is over and the country is once more besieged by the coronavirus. Intensive ...

PHILADELPHIA--(BUSINESS WIRE)--BioPhy, an innovative AI drug development company, today announced a partnership with Every Cure, a nonprofit initiative on a mission to unlock the full potential of ...